(4) DISCLOSURE OF EVIDENCE TO THE
MEDIA
248. The disclosure to the media of evidence to be
given to me, and references to the broad thrust of evidence given,
have been constant features of this inquiry. As I have said elsewhere
in this report, I do not believe that this has prejudiced in any
way my ability to deal fairly and objectively with the complaints
against Mr Duncan Smith. However, it has certainly been a continuing
concern to Mr Duncan Smith's advisers, who believe that it has
put him at a disadvantage and damaged his public reputation, and
have compared the apparent lack of protection for their client
unfavourably with the protections afforded by the Courts.
249. The procedural guidance approved by the Committee
makes clear that the disclosure of evidence in the course of an
inquiry may constitute a contempt of the House. A Member may draw
a possible contempt to the attention of the Speaker. Mr Duncan
Smith's advisers have argued that this avenue of redress is inadequate
and that some more immediate remedy should be available through
the Commissioner.
250. This is a sensitive and complex area. On the
one hand a complaint must be fairly and properly handled. That
must not be capable of being prejudiced by leaks to the media.
On the other hand overly heavy handed attempts to try to regulate
matters in this area are probably undesirable and doomed to failure.
I suggest that this important issue should be the subject of further
reflection away from the immediate consideration of the present
complaint, in the context of the review of the House's Code of
Conduct planned by the Committee.
Final word
251. The nature of the complaints in this case and
the circumstances in which my inquiry into them began and continued
have meant that the experience of the inquiry has been a difficult
and stressful one for a significant number of the witnesses who
have given me evidence. I am grateful for the way in which they
have conducted themselves. I am also grateful for the help of
my staff and colleagues in enabling me now to submit this report.
16 March 2004 Sir Philip Mawer
21 See Volume II, PCS Written Submission 1 (without
enclosures). Back
22
See Volume II, PCS Written Submission 2 (without enclosures).
Back
23
See Volume II, PCS Written Submission 3. Back
24
See Volume II, PCS Written Submission 49. Back
25
See Volume III, PCS Oral Evidence 1. Back
26
See Volume II, PCS Written Submission 4. Back
27
See Volume II, PCS Written Submission 2. Back
28
See Volume II, PCS Written Submission 50 (minus the detail of
its appendix). Back
29
See Volume II, PCS Written Submission 6. Back
30
See Volume II, PCS Written Submission 6, para 8. Back
31
See Volume III, PCS Oral Evidence 7, Qq 555-557. Back
32
See Volume II, PCS Written Submission 19. Back
33
See Volume II, PCS Written Submission 8. Back
34
See Volume II, PCS Written Submission 15. Back
35
See Volume II, PCS Written Submission 20, paras 3-4. Back
36
See Volume II, PCS Written Submission 5. Back
37
See Volume II, PCS Written Submission 5. Back
38
See Volume III, PCS Oral Evidence 9, 17 and 20. Back
39
See Volume II, PCS Written Submission 5. Back
40
See Volume II, PCS Written Submission 46. Back
41
See Volume II, PCS Written Submission 6. Back
42
See Volume II, PCS Written Submission 19. Back
43
See Volume II, PCS Written Submission 45. Back
44
See Volume II, PCS Written Submission 10. Back
45
See Volume II, PCS Written Submission 7, para 144. Back
46
See Volume II, PCS Written Submission 6, para 7. Back
47
See Volume II, PCS Written Submission 27, para 4-5. Back
48
See Volume II, PCS Written Submission 6, para 25. Back
49
See Volume III, PCS Oral Evidence 1, Q 3. Back
50
See Volume III, PCS Oral Evidence 20, Q 1973. Back
51
See Volume III, PCS Oral Evidence 20, Q 1978. Back
52
See Volume III, PCS Oral Evidence 20, Q 1983. Back
53
See Volume III, PCS Oral Evidence 20, Q 2000. Back
54
See Volume III, PCS Oral Evidence 20, Q 2000. Back
55
See Volume III, PCS Oral Evidence 20, Q 2007. Back
56
See Volume III, PCS Oral Evidence 20, Qq 2011-2012. Back
57
See Volume III, PCS Oral Evidence 20, Q 2018. Back
58
See Volume III, PCS Oral Evidence 20, Q 2054. Back
59
See Volume II, PCS Written Submission 13. Back
60
See Volume II, PCS Written Submission 13. Back
61
See Volume III, PCS Oral Evidence 9, Q 887. Back
62
See Volume III, PCS Oral Evidence 9, Q 893. Back
63
See Volume III, PCS Oral Evidence 9, Q 894. Back
64
See Volume II, PCS Written Submission 13. Back
65
See Volume II, PCS Written Submission 13. Back
66
See Volume III, PCS Oral Evidence 9, Q 896. Back
67
See Volume III, PCS Oral Evidence 9, Q 907. Back
68
See Volume III, PCS Oral Evidence 9, Q 921; and Volume II, PCS
Written Submission 13. Back
69
See Volume III, PCS Oral Evidence 9, Q 908. Back
70
See Volume III, PCS Oral Evidence 14, Q 1393. Back
71
See Volume III, PCS Oral Evidence 14, Q 1395. Back
72
See Volume III, PCS Oral Evidence 14, Q 1397. Back
73
See Volume III, PCS Oral Evidence 14, Q 1397. Back
74
See Volume II, PCS Written Submission 18; and PCS Oral Evidence
14, Qq 1403-1405. Back
75
See Volume II, PCS Written Submission 18. Back
76
See Volume II, PCS Written Submission 18. Back
77
See Volume II, PCS Written Submission, 18; and Volume III, PCS
Oral Evidence 14, Q 1402. Back
78
See Volume III, PCS Oral Evidence 11, Q 1130. Back
79
See Volume III, PCS Oral Evidence 11, Q 1131. Back
80
See Volume III, PCS Oral Evidence 11, Qq 1140, 1145. Back
81
See Volume III, PCS Oral Evidence 11, Qq 1146,1143, 1147. Back
82
See Volume II, PCS Written Submission 16. Back
83
See Volume II, PCS Written Submission 17. Back
84
See Volume III, PCS Oral Evidence 17, Q1709. Back
85
See Volume III, PCS Oral Evidence 17, Q 1711. Back
86
See Volume III, PCS Oral Evidence 17, Qq 1692-1693, 1713. Back
87
See Volume III, PCS Oral Evidence 17, Qq 1714, 1717. Back
88
See Volume III, PCS Oral Evidence 17, Qq 1682, 1687. Back
89
See Volume III, PCS Oral Evidence 3, Q 265. Back
90
See Volume II, PCS Written Submission 6, para 12. Back
91
See Volume II, PCS Written Submission 7, para 40. Back
92
See Volume II, PCS Written Submission 6. Back
93
See Volume II, PCS Written Submission 9, para 8; and Volume III,
PCS Oral Evidence 7, Qq 613-617. Back
94
See Volume II, PCS Written Submission 5. Back
95
See Volume II, PCS Written Submission 6, para 23. Back
96
See Volume II, PCS Written Submission 6, para 24, 27-28. Back
97
See Volume II, PCS Written Submission 6, para 18. Back
98
See Volume II, PCS Written Submission 6, paras 38-40. Back
99
See Volume II, PCS Written Submission 6, para 24. Back
100
See Volume II, PCS Written Submission 6, para 25. Back
101
See Volume III, PCS Oral Evidence 2, Q 80. Back
102
See Volume III, PCS Oral Evidence 2, Q 80. Back
103
See Volume III, PCS Oral Evidence 2, Q 80. Back
104
See Volume II, PCS Written Submission 6, para 26. Back
105
See Volume II, PCS Written Submission 6, para 31. Back
106
See Volume II, PCS Written Submission 6, para 67; and Volume III,
PCS Oral Evidence 2, Qq 210-212. Back
107
See Volume II, PCS Written Submission 6, para 29. Back
108
See Volume II, PCS Written Submission 6, para 30. Back
109
See Volume II, PCS Written Submission 6, para 30. Back
110
PCS Written Submission 6, para 31. Back
111
PCS Written Submission 6, para 32. Back
112
PCS Written Submission 6, paras 37, 34. Back
113
PCS Written Submission 6, paras 35-36. Back
114
PCS Written Submission 6, para 37. Back
115
PCS Written Submission 6, para 40. Back
116
See Volume II, PCS Written Submission 6, para 29; and Volume III,
PCS Oral Evidence 2, Qq 119-121, 238-243. Back
117
See Volume II, PCS Written Submission 7, para 41. Back
118
See Volume II, PCS Written Submission 7, para 42. Back
119
See Volume II, PCS Written Submission 7, para 50. Back
120
See Volume III, PCS Oral Evidence 3, Q 291. Back
121
See Volume II, PCS Written Submission 7, para 51. Back
122
See Volume II, PCS Written Submission 7, para 75. Back
123
See Volume III, PCS Oral Evidence 3, Q 296. Back
124
See Volume II, PCS Written Submission 7, para 52. Back
125
See Volume II, PCS Written Submission 7, para 35. Back
126
See Volume II, PCS Written Submission 7, para 52. Back
127
See Volume II, PCS Written Submission 7, para 133. Back
128
See Volume II, PCS Written Submission 7, para 64. Back
129
See Volume II, PCS Written Submission 7, para 30; and Volume III,
PCS Oral Evidence 3, Qq 351-357. Back
130
PCS Written Submission 7, para 129. Back
131
See Volume II, PCS Written Submission 7, paras 135, 137. Back
132
See Volume II, PCS Written Submission 7, paras 159-170. Back
133
See Volume II, PCS Written Submission 7, para 16. Back
134
See Volume II, PCS Written Submission 10, Addendum A, para 17. Back
135
See Volume II, PCS Written Submission 9, paras 6-7. Back
136
See Volume II, PCS Written Submission 27, para 4. Back
137
See Volume II, PCS Written Submission 27, para 5. Back
138
See Volume III, PCS Oral Evidence 24, Qq 2653-2655, 2674. Back
139
See Volume III, PCS Oral Evidence 24, Q 2660. Back
140
See Volume II, PCS Written Submission 9, para 8. Back
141
See Volume III, PCS Oral Evidence 15, Q 1500. Back
142
See Volume III, PCS Oral Evidence 15, Qq 1543-1546. Back
143
See Volume III, PCS Oral Evidence 7, Q 579. Back
144
See Volume III, PCS Oral Evidence 7, Q 588. Back
145
See Volume III, PCS Oral Evidence 22, Q 2301. Back
146
See Volume III, PCS Oral Evidence 7, Q 609. Back
147
See Volume III, PCS Oral Evidence 22, Q 2215. Back
148
See Volume III, PCS Oral Evidence 22, Q 2288. Back
149
See Volume III, PCS Oral Evidence 22, Q 2307. Back
150
See Volume II, PCS Written Submission 22. Back
151
See Volume III, PCS Oral Evidence 21, Q 2093. Back
152
See Volume III, PCS Oral Evidence 21, Q 2100. Back
153
See Volume III, PCS Oral Evidence 21, Q 2104. Back
154
See Volume III, PCS Oral Evidence 7, Q 584. Back
155
See Volume III, PCS Oral Evidence 7, Q 627. Back
156
See Volume III, PCS Oral Evidence 22, Q 2321. Back
157
See Volume III, PCS Oral Evidence 24, Q 2660. Back
158
See Volume II, PCS Written Submission 7a; and Volume III, PCS
Oral Evidence 4, Q 460. Back
159
PCS Written Submission 15, para 5. Back
160
PCS Written Submission 15, para 6. Back
161
See Volume III, PCS Oral Evidence 12, Q 1215. Back
162
See Volume III, PCS Oral Evidence 13, Qq 1318, 1325. Back
163
See Volume III, PCS Oral Evidence 13, Qq 1327-1328, 1334. Back
164
See Volume III, PCS Oral Evidence 13, Q 1340. Back
165
See Volume II, PCS Written Submission 19, para 22. Back
166
See Volume III, PCS Oral Evidence 18, Q 1776. Back
167
See Volume III, PCS Oral Evidence 18, Q 1777. Back
168
See Volume II, PCS Written Submission 6, para 40. Back
169
See Volume II, PCS Written Submission 12. Back
170
See Volume II, PCS Written Submission 23. Back
171
See Volume II, PCS Written Submission 6, para 101. Back
172
See Volume II, PCS Written Submission 29. Back
173
See Volume III, PCS Oral Evidence 2, Qq 163-164. Back
174
See Volume II, PCS Written Submissions 30; 31; and 42. Back
175
See Volume II, PCS Written Submission 33. Back
176
See Volume II, PCS Written Submission 35. Back
177
See Volume II, PCS Written Submission 34. Back
178
See Volume II, PCS Written Submission 36. Back
179
See Volume II, PCS Written Submissions 37-41. Back
180
See Volume II, PCS Written Submission 6, para 79. Back
181
See Volume II, PCS Written Submission 32. Back
182
See Volume II, PCS Written Submission 42. Back
183
See Volume III, PCS Oral Evidence 1, Q 28. Back
184
See Volume II, PCS Written Submission 43. Back
185
See Volume III, PCS Oral Evidence 19, Qq 1927-1937. Back
186
See Volume III, PCS Oral Evidence 19, Qq 1877-1892. Back
187
See Volume II, PCS Written Submission 44. Back
188
See Volume III, PCS Oral Evidence 9, Q 966; and 22, Q 2328. Back
189
See Volume II, PCS Written Submission 49; and Volume III, PCS
Oral Evidence 22, Q 2329. Back
190
See Volume III, PCS Oral Evidence 22, Q 2330. Back
191
See Volume III, PCS Oral Evidence 9, Q 968. Back
192
See Volume II, PCS Written Submission 25, para 57. Back
193
See Volume III, PCS Oral Evidence 22, Q 2329. Back
194
See Volume III, PCS Oral Evidence 22, Q 2335. Back
195
See Volume II, PCS Written Submission 25, para 37. Back
196
See Volume III, PCS Oral Evidence 21, Q 2182. Back
197
See Volume II, PCS Written Submission 25, para 38. Back
198
See Volume II, PCS Written Submission 13. Back
199
See Volume III, PCS Oral Evidence 23, Q 2559. Back
200
See Volume II, PCS Written Submission 7, para 140. Back
201
See Volume III, PCS Oral Evidence 3, Q 322. Back
202
See Volume III, PCS Oral Evidence 13, Q 1342. Back
203
See Volume II, PCS Written Submission 13, and 25, paras 14-17;
and Volume III; PCS Oral Evidence 22, Q 2369. Back
204
See Volume II, PCS Written Submission 25, para 57. Back
205
See Volume III, PCS Oral Evidence 23, Q 2466. Back
206
See Volume III, PCS Oral Evidence 9, Q 887. Back
207
See Volume III, PCS Oral Evidence 9, Q 886. Back
208
See Volume II, PCS Written Submission 25, para 29.. Back
209
See Volume III, PCS Oral Evidence 9, Q 886. Back
210
See Volume III, PCS Oral Evidence 9, Q931. Back
211
See Volume III, PCS Oral Evidence 9, Q 921. Back
212
See Volume II, PCS Written Submission 18. Back
213
See Volume III, PCS Oral Evidence 10, Q 1013. Back
214
See Volume III, PCS Oral Evidence 9, Q 928. Back
215
See Volume III, PCS Oral Evidence 9, Qq 928, 930. Back
216
See Volume II, PCS Written Submission 19, para 35. Back
217
See Volume II, PCS Written Submission 19, para 35. Back
218
See Volume II, PCS Written Submission 19, paras 36-37. Back
219
See Volume III, PCS Oral Evidence 16, Qq 1564, 1566, 1569, 1570. Back
220
See Volume III, PCS Oral Evidence 14, Q 1436. Back
221
See Volume II, PCS Written Submission 18; and Volume III, PCS
Oral Evidence 14, Q 1437; 9, Q 921; and 10, Q 1019. Back
222
See Volume III, PCS Oral Evidence 18, Qq 1827-1828. Back
223
See Volume II, PCS Written Submission 13,; and 8; and Volume III,
PCS Oral Evidence 9, Q 927; and 14, Q 1440. Back
224
See Volume III, PCS Oral Evidence 16, Q 1557; and 14, Q 1456. Back
225
See Volume II, PCS Written Submission 5, para 5. Back
226
See Volume II, PCS Written Submission 7, para 37. Back
227
See Volume II, PCS Written Submission 7, para 37. Back
228
See Volume II, PCS Written Submission 7, para 37. Back
229
See Volume II, PCS Written Submission 6, paras 56, 62, 65-66. Back
230
See Volume II, PCS Written Submission 51. Back
231
See Volume III, PCS Oral Evidence 23, Qq 2458, 2486, 2474. Back
232
See Volume III, PCS Oral Evidence 5, Q 511. Back
233
See Volume II, PCS Written Submission 25, para 33. Back
234
See Volume III, PCS Oral Evidence 23, Q 2570. Back
235
See Volume II, PCS Written Submission 25, para 34. Back
236
See Volume II, PCS Written Submission 46. Back
237
See Volume III, PCS Oral Evidence 9, Q 955. Back
238
See Volume III, PCS Oral Evidence 9, Q 938. Back
239
See Volume III, PCS Oral Evidence 9, Q 946. Back
240
See Volume III, PCS Oral Evidence 9, Q 943. Back
241
See Volume II, PCS Written Submission 7, paras 150-151; and Volume
III, PCS Oral Evidence 3, Q 338. Back
242
See Volume III, PCS Oral Evidence 3, Q 844. Back
243
See Volume II, PCS Written Submission 15, para 13; and Volume
III, PCS Oral Evidence 4, Q 421. Back
244
See Volume II, PCS Written Submission 15, para 14. Back
245
See Volume III, PCS Oral Evidence 4, Q 422. Back
246
See Volume III, PCS Oral Evidence 4, Q 425. Back
247
See Volume III, PCS Oral Evidence 4, Q 427. Back
248
See Volume II, PCS Written Submission 14. Back
249
See Volume III, PCS Oral Evidence 14, Q 1471. Back
250
See Volume III, PCS Oral Evidence 10, Q 1038. Back
251
See Volume III, PCS Oral Evidence 13, Qq 1373, 1378. Back
252
See Volume III, PCS Oral Evidence 13, Q 1385. Back
253
See Volume III, PCS Oral Evidence 16, Q 1599. Back
254
See Volume II, PCS Written Submission 7, para 68. Back
255
See Volume III, PCS Oral Evidence 3, Q 345. Back
256
See Volume II, PCS Written Submission 7, para 68; and Volume III,
PCS Oral Evidence 3, Q 335. Back
257
See Volume II, PCS Written Submission 7, para 69. Back
258
See Volume II, PCS Written Submission 7, para 69. Back
259
See Volume II, PCS Written Submission 13. Back
260
See Volume II, PCS Written Submission 7, para 71. Back
261
See Volume II, PCS Written Submission 13. Back
262
See Volume II, PCS Written Submissions 47-48. Back
263
See Volume III, PCS Oral Evidence 14, Q 1465. Back
264
See Volume III, PCS Oral Evidence 10, Q 1044. Back
265
See Volume III, PCS Oral Evidence 13, Qq 1375, 1379-1381. Back
266
See Volume III, PCS Oral Evidence 16, Q 1590. Back
267
See Volume III, PCS Oral Evidence 4, Q 455. Back
268
See Volume III, PCS Oral Evidence 12, Q 1264. Back
269
See Volume II, PCS Written Submission 19, para 40. Back
270
See Volume III, PCS Oral Evidence 1, Q 3. Back
271
See Volume II, PCS Written Submission 49; and Volume III, PCS
Oral Evidence 1, Q 5. Back
272
See Volume II, PCS Written Submission 18; and Volume III, PCS
Oral Evidence 14, Qq 1277, 1408-1418. Back
273
See Volume II, PCS Written Submission 13. Back
274
See Volume III, PCS Oral Evidence 10, Q 1089. Back
275
See Volume II, PCS Written Submission 25, para 28. Back
276
See Volume II, PCS Written Submission 25, para 29. Back
277
See Volume II, PCS Written Submission 25, para 15. Back
278
See Volume II, PCS Written Submission 10, paras 4f)-g). Back
279
See Volume II, PCS Written Submission 10, para 9b). Back
280
See Volume II, PCS Written Submission 10, para 9b). Back
281
See Volume II, PCS Written Submission 10, para 5, 9f). Back
282
See Volume II, PCS Written Submission 10, Addendum A, para 13. Back
283
See Volume III, PCS Oral Evidence 8, Q 703. Back
284
See Volume III, PCS Oral Evidence 8, Qq 704, 719. Back
285
See Volume II, PCS Written Submission 25, paras 22-23. Back
286
See Volume III, PCS Oral Evidence 23, Q 2530. Back
287
See Volume II, PCS Written Submission 7, para 126. Back
288
See Volume III, PCS Oral Evidence 3, Q 307; and Volume II, PCS
Written Submission 7. Back
289
Committee on Standards and Privileges, Second Report of Session
2000-01: Complaints against Mr John Maxton and Dr John Reid
(HC 89). Back
290
See Volume III, PCS Oral Evidence 3, Qq 312, 311. Back
291
See Volume II, PCS Written Submission 7, para 12. Back
292
See Volume II, PCS Written Submission 7, para 49. Back
293
See Volume II, PCS Written Submission 6, para 104. Back
294
Letter to the Commissioner from Mr Andrew Walker, 10 December
2003, not appended. Back
295
See Volume II, PCS Written Submission 26. Back
296
Letter to the Commissioner from Mr Andrew Walker, 26 January 2004,
not appended. Back
297
See Volume II, PCS Written Submission 52. Back
298
See Volume II, PCS Written Submission 53. Back
299
See Volume II, PCS Written Submission 13. Back
300
See Volume III, PCS Oral Evidence 9, Q 882. Back
301
See Volume II, PCS Written Submission 25, para 62. Back
302
See Volume II, PCS Written Submission 10, para 10d); 11; 25, para
62; and Volume III, PCS Oral Evidence 8, Q 727; and 23, Q 2623. Back
303
See Volume II, PCS Written Submission 52. Back
304
See Volume III, PCS Oral Evidence 3, Q 276. Back
305
See Volume II, PCS Written Submission 52. Back
306
See Volume II, PCS Written Submission 50. Back
307
See Volume II, PCS Written Submission 12. Back
308
See Volume II, PCS Written Submission 7, para 49. Back
309
See Volume II, PCS Written Submission 6, para 104. Back
310
See Volume II, PCS Written Submission 25, para 3, 62. Back
311
Committee on Standards and Privileges, Second Report of Session
2000-01 (HC 89), para 20. Back
312
Committee on Standards and Privileges, Third Report of Session
2002-03: Complaints against Mr Michael Trend (HC 435). Back
313
See Volume III, PCS Oral Evidence 10, Q 1003. Back
314
See Volume III, PCS Oral Evidence 5, Q 509. Back
315
See Volume III, PCS Oral Evidence 4, Q 500. Back
316
See Volume II, PCS Written Submission 6, para 104. Back
317
Committee on Standards and Privileges, Second Report of Session
2000-01 (HC 89), para 45. Back
318
See Volume II, PCS Written Submission 10, Addendum A, para 13. Back
319
See Volume II, PCS Written Submission 50. Back
320
Committee on Standards and Privileges, Fifth Report of Session
2002-03: Complaints against Mr Clive Betts (HC 947). Back